MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkin"

  • 2019 International Congress

    Detection of genetic modifiers in PRKN

    K. Ogaki, H. Nakaoka, K. Daida, A. Hayashida, A. Ikeda, Y. Li, H. Yoshino, M. Funayama, K. Nishioka, I. Inoue, N. Hattori (Tokyo, Japan)

    Objective: In this study, we investigate the Hypothesis 1 using Next-generation sequencing (NGS). Background: In 1998, we reported homozygous mutations of PRKN as the causative…
  • 2019 International Congress

    Olfactory dysfunction in Parkinson’s disease

    N. Jalami, H. Bentahar, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: It is to propose a psychophysical test of the olfactory function. Its originality is to use Moroccan odorous products belonging to our culture to…
  • 2019 International Congress

    Park-Ease Trial: A Randomized Controlled Trial to Study the Efficacy of Exercises in Early-Stage Parkinson’s Disease

    R. Swarnakar, S. Wadhwa, S. V, V. Goyal, V. Sreenivas (New Delhi, India)

    Objective: To evaluate the efficacy of exercises in early-stage Parkinson’s Disease by observing improvement in motor symptoms assessed by Unified Parkinson’s Disease Rating Scale (UPDRS)…
  • 2019 International Congress

    SNP assessment and gene expression analysis of alpha-synuclein (SNCA), LRRK2 gene and parkin (PRKN) gene in chewing tobacco exposures and find out the risk of Parkinson’s disease

    R. Ramachandran, E. E, V. Uthayakumar (Erode, India)

    Objective: We aimed to find out the molecular assessment of the risk of Parkinson’s disease (PD) in tobacco exposure through the SNP and gene expression…
  • 2019 International Congress

    How Commonly Does Parkinson’s Disease Present with Dystonia?

    P. Popa, C. Brown, C. Henchcliffe, H. Sarva (New York, NY, USA)

    Objective: To review dystonia as the presenting feature of Parkinson’s disease (PD). Background: Dystonia in PD is most commonly described as a levodopa complication. It…
  • 2019 International Congress

    Screening of mutations in PARK2 gene and Dopamine levels in Parkinson’s disease (PD) patients in Coimbatore population, India

    B. Vellingiri, D. Venkatesan (Coimbatore, India)

    Objective: The aim of the present study was to perform the mutational screening of PARK2 gene and dopamine level in PD patients of Coimbatore population,…
  • 2019 International Congress

    Enhancing the Proteasomal Degradation of Alpha Synuclein: “The Hallmark” to attenuating the Progression of Parkinson’s Disease

    B. Adebisi, M. Adeleke (Osogbo, Nigeria)

    Objective: The research aimed at preventing the accumulation of Alpha Synuclein in order to prevent it's accumulation.  It is imperative that we also establish that…
  • 2019 International Congress

    Peripheral Blood Mononuclear Cells (PBMCs) are Useful Biomarkers of Mitochondrial Dysfunction in Parkinson Disease Patients with Pathogenic Parkin and LRRK2 Mutations

    P. Campbell, J. Harvey, A. Costantini, H. Morris, A. Schapira (London, United Kingdom)

    Objective: To investigate the use of PBMCs as a biomarker of mitochondrial dysfunction in Parkinson disease (PD) patients carrying pathogenic parkin or LRRK2 mutations. Background:…
  • 2019 International Congress

    The role of mitochondria in modifying penetrance of Parkin gene variants

    M. Castelo, J. Trinh, A. Zanon, J. Rainer, P. Bauer, K. Kandaswamy, M. Werber, A. Rolfs, A. Grunewald, M. Borsche, K. Lohmann, C. Klein, P. Pramstaller, I. Pichler, A. Hicks (Bolzano, Italy)

    Objective: To understand whether mitochondrial DNA (mtDNA) mutation load can modify the penetrance of variants in the Parkinson’s disease (PD) causing gene PRKN (Parkin), in…
  • 2019 International Congress

    PRKN Positive Parkinson’s Disease Masked as Dopa-Responsive Dystonia

    S. Chiu, A. Elkouzi, L. Almeida (Gainesville, FL, USA)

    Objective: To report a Parkinson’s disease (PD) patient with PRKN mutation initially diagnosed with dopa-responsive dystonia (DRD), unmasked after developing signs of parkinsonian disease progression.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley